| The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting G Dranitsaris, A Molassiotis, M Clemons, E Roeland, L Schwartzberg, ... Annals of Oncology 28 (6), 1260-1267, 2017 | 213 | 2017 |
| Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide F Scotté, P Bossi, E Carola, T Cudennec, P Dielenseger, F Gomes, ... Annals of Oncology 29 (8), 1718-1726, 2018 | 137 | 2018 |
| Evidence-based management of chemotherapy-induced nausea and vomiting: a position statement from a European cancer nursing forum C Vidall, P Dielenseger, C Farrell, E Lennan, P Muxagata, ... Ecancermedicalscience 5, 2011 | 58 | 2011 |
| Evaluation of antiemetic practices for prevention of chemotherapy-induced nausea and vomiting (CINV): results of a European oncology nurse survey P Dielenseger, S Börjeson, C Vidall, A Young, P Jahn Supportive Care in Cancer 27, 4099-4106, 2019 | 41 | 2019 |
| SOR SAVOIR PATIENT fatigue et cancer information à l'usage des personnes malades et de leurs proches P DIELCNSCGER, JM DILHUYDY, N HUBERT, M MESLIER, S ROSMAN, ... Bulletin du cancer 93 (12), 1213-1227, 2006 | 12 | 2006 |
| A new perspective in the treatment of non-small-cell lung cancer (NSCLC). Role of afatinib: An oral and irreversible ErbB family blocker M Wislez, D Malka, J Bennouna, L Mortier, RJ Bensadoun, J Sicard, ... Bulletin du cancer 101 (6), 647-652, 2014 | 8 | 2014 |
| Use of sorafenib in patients with hepatocellular or renal carcinoma O Rosmorduc, C Chevreau, P Dielenseger, S Ederhy, F Goldwasser, ... Gastroenterologie Clinique et Biologique 34 (3), 161-167, 2010 | 6 | 2010 |
| Helping patients discuss CINV management: development of a Patient Charter A Young, P Dielenseger, PF Ortega, DF Perez, P Jones, E Lennan, ... ecancermedicalscience 7, 2013 | 5 | 2013 |
| Pain related to repeated invasive procedures in oncology: Improvement of management between 1998 and 2004 I Krakowski, M Di Palma, B George, D Serin, D Feminier, P Dielenseger, ... Journal of Clinical Oncology 23 (16_suppl), 8247-8247, 2005 | 5 | 2005 |
| Evaluation of Antiemetic Practices for Prevention of Chemotherapy-induced Nausea and Vomiting (CINV): Results of a European Oncology Nurse Survey P Dielenseger, S Borjeson, C Vidall, A Young, P Jahn Annals of Oncology 28, v547, 2017 | 2 | 2017 |
| Bon usage du sorafénib chez les patients pris en charge pour un carcinome hépatocellulaire ou un cancer du rein O Rosmorduc, C Chevreau, P Dielenseger, S Ederhy, F Goldwasser, ... Gastroentérologie clinique et biologique 34 (3), 161-167, 2010 | 2 | 2010 |
| Guidelines for treatment of hepatocellular or renal carcinoma with sorafenib O Rosmorduc, C Chevreau, P Dielenseger, S Ederhy, F Goldwasser, ... GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE 34 (3), 161-167, 2010 | 2 | 2010 |
| Gestion pratique des inhibiteurs de PARP: Un consensus national DELPHI F Selle, JJ Boffa, G Etienne, A Angelergues, P Augereau, D Berton, ... Bulletin du Cancer 109 (12), 1245-1261, 2022 | 1 | 2022 |
| 1577P Optimizing the management of PARP inhibitors in clinical practice: Results of a DELPHI French consensus F Selle, F Scotté, JJ Boffa, G Etienne, A Angelergues, P Augereau, ... Annals of Oncology 33, S1267, 2022 | 1 | 2022 |
| The role of “Planner” at Gustave-Roussy: an innovative profession in early clinical research within the organisation of the patient care pathway S Lancereau, K Fréon, C Vincent, M Guibourt, P Dielenseger, G Chartier, ... Innovations & thérapeutiques en oncologie 2 (5), 251-256, 2016 | 1 | 2016 |
| Nouvelle perspective de traitement dans le cancer bronchique non à petites cellules (CBNPC). Place de l’afatinib: Un inhibiteur oral et irréversible de la famille ErbB M Wislez, D Malka, J Bennouna, L Mortier, RJ Bensadoun, J Sicard, ... Bulletin du cancer 101 (6), 647-652, 2014 | 1 | 2014 |
| Cancer and fatigue Information dedicated to cancer patients and relatives P Dielenseger, JM Dilhuydy, S Brusco, L Chazot, JY Blay, B Bové, ... Bulletin du Cancer 93 (12), 1213-1227, 2006 | 1 | 2006 |
| Traduction et republication de:«Traitement de la maladie thromboembolique veineuse associée au cancer chez les patients en soins palliatifs» P Debourdeau, MA Sevestre, L Bertoletti, D Mayeur, P Girard, F Scotté, ... La Revue de Médecine Interne, 2024 | | 2024 |
| Traduction et republication de:«Thrombose veineuse profonde du membre supérieur associée à un cathéter veineux central chez les patients cancéreux: diagnostic et prise en … A Élias, P Debourdeau, O Espitia, MA Sevestre, P Girard, I Mahé, ... La Revue de Médecine Interne, 2024 | | 2024 |
| Traduction et republication de:«Maladie thromboembolique veineuse récidivante chez les patients cancéreux anticoagulés: diagnostic et traitement» L Bertoletti, P Girard, A Élias, O Espitia, J Schmidt, F Couturaud, I Mahé, ... La Revue de Médecine Interne, 2024 | | 2024 |
